Provided by Tiger Fintech (Singapore) Pte. Ltd.

Information

5.75
+0.09001.59%
Post-market: 5.64-0.1100-1.91%19:20 EDT
Volume:193.48K
Turnover:1.10M
Market Cap:277.12M
PE:36.64
High:5.78
Open:5.67
Low:5.64
Close:5.66
52wk High:6.01
52wk Low:2.95
Shares:48.20M
Float Shares:34.23M
Volume Ratio:0.66
T/O Rate:0.57%
Dividend:0.18
Dividend Rate:3.13%
EPS(TTM):0.1569
EPS(LYR):0.0582
ROE:8.29%
ROA:3.59%
PB:2.95
PE(LYR):98.81

Loading ...

Press Release: Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

Dow Jones
·
6 hours ago

Press Release: Crown Point Provides Update on Acquisition of El Tordillo, La Tapera & Puesto Quiroga Concessions and Discloses Reserve Information

Dow Jones
·
8 hours ago

New Stock News | Binhua Biosciences Submits IPO Application to HKEX, Advances BS001 to Phase III Clinical Trial for Melanoma in China

Stock News
·
Yesterday

Anavex announces publication on oral blarcamesine Phase IIb/III trial

TIPRANKS
·
Yesterday

Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial

GlobeNewswire
·
Yesterday

Terra Innovatum and GSR III Acquisition Corp. Remind Shareholders to Vote and Approve the Business Combination Prior to the October 7 Extraordinary General Meeting of Shareholders

GlobeNewswire
·
Yesterday

Hebei Yichen Releases Supplemental Information on Executive Compensation

TIPRANKS
·
Yesterday

INNOGEN-B (02591) Completes First Patient Dosing in China for Phase III Clinical Trial of Core Product Isupaglutide α for Obesity and Overweight Treatment

Stock News
·
Yesterday

Alibaba Health Information Technology Stock Climbs 1.8% in Hong Kong

Dow Jones
·
Yesterday

Hong Kong Stock Movement | YIDU TECH (02158) Surges Over 14% as AI Expected to Empower Clinical Trials, Subsidiary Wins Bid for SMR001 Eye Drops Phase III Clinical Research Project

Stock News
·
Yesterday

RBC Capital Keeps Their Hold Rating on 3i Group plc (III)

TIPRANKS
·
Yesterday

Minmetals Land Limited Announces Trading Halt Pending Inside Information Release

TIPRANKS
·
Yesterday

New Stock Update | MacroAir Seeks HKEx Listing with Core Product MT1013 in Phase III Clinical Trials

Stock News
·
Yesterday

Locus Cell's Zhubei Smart GMP Facility Secures First International Phase III CDMO Manufacturing MOU with Cambium Bio

prnewswire
·
Yesterday

GSR III Acquisition Corp Secures $31.8M PIPE Financing

TIPRANKS
·
Yesterday

IMMUNEONCO-B (01541): IMM0306 Phase III Clinical Trial Application for Treatment of Follicular Lymphoma

Stock News
·
Sep 29

Franchetti S.p.A. Updates Key Information Document for 2022-2025 Warrant

TIPRANKS
·
Sep 29

CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO

GlobeNewswire
·
Sep 29

Emdoor Information to Acquire Controlling Stake in Two Entities

MT Newswires Live
·
Sep 29

Alpen Co., Ltd. Discloses Controlling Shareholder Information

TIPRANKS
·
Sep 29